Medical Cannabis Remediation and Testing Rulemaking Approval Resolution of 2025

This resolution (PR 26-0317) approves rules allowing licensed medical cannabis businesses in D.C. to fix products that fail testing for issues that can be corrected without patient harm - rather than destroying them. It directly affects businesses operating under D.C.'s Medical Cannabis Program by enabling remediation (e.g., removing contaminants) and repurposing usable products. The rules align D.C. with other states like Virginia and reduce waste by preventing unnecessary product destruction. The resolution seeks Council approval for these finalized rules, which were adopted by the Alcoholic Beverage and Cannabis Board and published in the District of Columbia Register.